263 related articles for article (PubMed ID: 28665938)
1. Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up.
Lin KY; Cheng CY; Li CW; Yang CJ; Tsai MS; Liu CE; Lee YT; Tang HJ; Wang NC; Lin TY; Lee YC; Lin SP; Huang YS; Zhang JY; Ko WC; Cheng SH; Hung CC;
PLoS One; 2017; 12(6):e0179870. PubMed ID: 28665938
[TBL] [Abstract][Full Text] [Related]
2. Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
Wu PY; Cheng CY; Liu CE; Lee YC; Yang CJ; Tsai MS; Cheng SH; Lin SP; Lin DY; Wang NC; Lee YC; Sun HY; Tang HJ; Hung CC
PLoS One; 2017; 12(2):e0171596. PubMed ID: 28222098
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan.
Tseng YT; Yang CJ; Chang SY; Lin SW; Tsai MS; Liu WC; Wu PY; Su YC; Luo YZ; Yang SP; Hung CC; Chang SC
Int J Infect Dis; 2014 Dec; 29():12-7. PubMed ID: 25312984
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single and boosted protease inhibitor versus nonnucleoside reverse transcriptase inhibitor-containing cART regimens in antiretroviral-naïve patients starting cART after January 1, 2000.
Mocroft ; Horban ; Clumeck ; Stellbrink ; Monforte dA; Zilmer ; Kirk ; Gatell ; Phillips ; Lundgren ;
HIV Clin Trials; 2006; 7(6):271-84. PubMed ID: 17208897
[TBL] [Abstract][Full Text] [Related]
5. Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir.
Abgrall S; Yeni PG; Bouchaud O; Costagliola D;
Clin Infect Dis; 2007 Jan; 44(1):120-7. PubMed ID: 17143827
[TBL] [Abstract][Full Text] [Related]
6. Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada.
Samji H; Taha TE; Moore D; Burchell AN; Cescon A; Cooper C; Raboud JM; Klein MB; Loutfy MR; Machouf N; Tsoukas CM; Montaner JS; Hogg RS;
HIV Med; 2015 Feb; 16(2):76-87. PubMed ID: 25174373
[TBL] [Abstract][Full Text] [Related]
7. Sustainability of first-line antiretroviral regimens: findings from a large HIV treatment program in western Kenya.
Braitstein P; Ayuo P; Mwangi A; Wools-Kaloustian K; Musick B; Siika A; Kimaiyo S
J Acquir Immune Defic Syndr; 2010 Feb; 53(2):254-9. PubMed ID: 19745752
[TBL] [Abstract][Full Text] [Related]
8. Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir.
Abgrall S; Yeni PG; Bouchaud O; Costagliola D;
AIDS; 2006 Oct; 20(16):2099-106. PubMed ID: 17053356
[TBL] [Abstract][Full Text] [Related]
9. Trends and the associated factors of optimal immunological response and virological response in late anti-retroviral therapy initiation HIV cases in Taiwan from 2009 to 2020.
Lee CY; Lin YP; Lin CY; Chen TC; Kuo SH; Lo SH; Wang SF; Lu PL
J Infect Public Health; 2024 Feb; 17(2):339-348. PubMed ID: 38194765
[TBL] [Abstract][Full Text] [Related]
10. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.
Cardoso SW; Luz PM; Velasque L; Torres TS; Tavares IC; Ribeiro SR; Moreira RI; Veloso VG; Moore RD; Grinsztejn B
BMC Infect Dis; 2014 Dec; 14():699. PubMed ID: 25523385
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients.
Kowalska JD; Kubicka J; Siwak E; Pulik P; Firląg-Burkacka E; Horban A;
AIDS Res Ther; 2016; 13():2. PubMed ID: 26744599
[TBL] [Abstract][Full Text] [Related]
13. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
14. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.
Cesar C; Jenkins CA; Shepherd BE; Padgett D; Mejía F; Ribeiro SR; Cortes CP; Pape JW; Madero JS; Fink V; Sued O; McGowan C; Cahn P;
Lancet HIV; 2015 Nov; 2(11):e492-500. PubMed ID: 26520929
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.
Kiboneka A; Wangisi J; Nabiryo C; Tembe J; Kusemererwa S; Olupot-Olupot P; Joffres M; Anema A; Cooper CL; Montaner JS; Mills EJ
AIDS; 2008 Nov; 22(18):2493-9. PubMed ID: 19005272
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral Regimen Durability and Success in Treatment-Naive and Treatment-Experienced Patients by Year of Treatment Initiation, United States, 1996-2011.
Sheth AN; Ofotokun I; Buchacz K; Armon C; Chmiel JS; Hart RL; Baker R; Brooks JT; Palella FJ
J Acquir Immune Defic Syndr; 2016 Jan; 71(1):47-56. PubMed ID: 26334737
[TBL] [Abstract][Full Text] [Related]
17. Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan.
Liu WD; Tsai WC; Hsu WT; Shih MC; Chen MY; Sun HY; Hsieh SM; Sheng WH; Chuang YC; Cheng A; Lin KY; Huang YS; Huang SH; Huang YC; Chen GJ; Wu PY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2020 Dec; 53(6):936-945. PubMed ID: 31105037
[TBL] [Abstract][Full Text] [Related]
18. Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia.
Boettiger DC; Sudjaritruk T; Nallusamy R; Lumbiganon P; Rungmaitree S; Hansudewechakul R; Kumarasamy N; Bunupuradah T; Saphonn V; Truong KH; Yusoff NKN; Do VC; Nguyen LV; Razali KAM; Fong SM; Kurniati N; Kariminia A
J Adolesc Health; 2016 Apr; 58(4):451-459. PubMed ID: 26803201
[TBL] [Abstract][Full Text] [Related]
19. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
[TBL] [Abstract][Full Text] [Related]
20. Determinants of antiretroviral therapy initiation and treatment outcomes for people living with HIV in Vietnam.
Tran DA; Shakeshaft A; Ngo AD; Mallitt KA; Wilson D; Doran C; Zhang L
HIV Clin Trials; 2013; 14(1):21-33. PubMed ID: 23372112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
